🔥 Trending Gene Editing Trial Leads to Tragic Death of 6-Year-Old Girl in Shanghai; Investi

A 6-year-old girl in China, identified as "Mei" (a pseudonym), tragically died in March 2025 after receiving an experimental gene-editing therapy in Shanghai. This incident, which was not publicly disclosed until a recent investigation by Science and Retraction Watch, has raised significant concerns about ethical oversight and transparency in biomedical research in China ³⁵⁹¹⁰.

Background of the Case

Mei suffered from Snijders-Blok-Campeau syndrome, a rare neurodevelopmental syndrome caused by a mutation in a specific gene ³¹⁰. While the condition was described as non-life-threatening, it caused developmental delays ⁵¹⁰. Her parents, seeking a cure for their daughter's condition, reportedly paid more than $800,000 (approximately $860,000 according to some sources) for the experimental treatment ²⁸¹⁰.

The Experimental Therapy

The gene-editing therapy Mei received was designed to target the brain, aiming to rewrite the mutated gene in her neurons to restore the necessary DNA base and enable the production of a vital protein ¹. This made her the first person in the world to receive a gene-editing therapy directed at the brain ¹⁶¹⁰. The effort was led by neuroscientist Zilong Qiu from the Shanghai Jiao Tong University's brain center ¹.

The Unreported Death and Subsequent Investigation

Mei died a week after receiving the treatment in March 2025 ⁶⁹. Despite the gravity of the event, her death was not publicly reported by the researchers or the institution involved ⁴⁵⁹. The investigation by Science and Retraction Watch, published in July 2026, brought this previously undisclosed death to light ³⁵.

Following the revelations, Shanghai Jiao Tong University School of Medicine announced that it would launch a "comprehensive investigation" into the incident ⁴. The university promised "serious action" based on its findings ⁴. Zilong Qiu, the neuroscientist leading the research, is now under investigation by his university ⁷.

Ethical and Regulatory Concerns

This case has sparked a global discussion on the ethical implications of experimental gene therapies, particularly in the context of clinical trials in China. Critics point to the lack of transparency surrounding Mei's death and question the regulatory framework and oversight mechanisms in place for such advanced biomedical research ³⁹. The fact that the death remained hidden for over a year highlights potential systemic issues in reporting adverse events in experimental treatments ⁷⁹. The incident underscores the critical need for robust ethical guidelines, stringent reporting requirements, and international collaboration to ensure patient safety and maintain public trust in groundbreaking scientific research.